Loading...
XAMS
WKL
Market cap18bUSD
Sep 18, Last price  
68.16EUR
1D
-2.74%
1Q
15.80%
Jan 2017
98.02%
Name

Wolters Kluwer NV

Chart & performance

D1W1MN
XAMS:WKL chart
P/E
12.25
P/S
2.51
EPS
5.56
Div yield, %
3.47%
Shrs. gr., 5y
-2.76%
Rev. gr., 5y
5.88%
Revenues
6.13b
+3.53%
3,693,000,0003,413,000,0003,374,000,0003,425,000,0003,556,000,0003,354,000,0003,603,000,0003,565,000,0003,660,000,0004,208,000,0004,297,000,0004,422,000,0004,260,000,0004,612,000,0004,603,000,0004,771,000,0005,453,000,0005,584,000,0005,916,000,0006,125,000,000
Net income
1.26b
+16.44%
321,000,000918,000,000313,000,000118,000,000288,000,000120,000,000312,000,000345,000,000473,000,000423,000,000489,000,000636,000,000656,000,000669,000,000721,000,000728,000,0001,027,000,0001,007,000,0001,079,000,0001,256,376,763
CFO
1.60b
-3.08%
535,000,000512,000,000521,000,000510,000,000546,000,000536,000,000619,000,000630,000,000645,000,000843,000,000927,000,000940,000,000934,000,0001,102,000,0001,197,000,0001,292,000,0001,582,000,0001,545,000,0001,654,000,0001,603,129,065
Dividend
Sep 01, 20261.01 EUR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Wolters Kluwer N.V., founded in 1836 and headquartered in Alphen aan den Rijn, the Netherlands, operates as a global provider of specialized information, software, and services. The company's extensive reach covers Europe, the United States, Canada, the Asia Pacific region, and other international markets. Its diverse offerings are organized into four primary business divisions. The Health segment delivers clinical technology and evidence-based solutions that are instrumental in fostering effective decision-making and improving patient outcomes across the healthcare spectrum. This segment serves a wide array of clients, including hospitals, various healthcare providers, individual clinicians, students, medical and nursing schools, libraries, retail pharmacies, payers, and life sciences organizations. The Tax & Accounting segment offers solutions designed to enhance productivity, facilitate adaptation to evolving conditions, and achieve superior results for tax, accounting, and audit professionals. Its customer base includes accounting firms, corporate finance, tax, and auditing departments, government bodies, libraries, and universities. The Governance, Risk & Compliance (GRC) segment provides technology-driven services and solutions that address legal entity adherence, legal operations management, banking product conformity, and regulatory reporting requirements. This division caters to legal, compliance, and risk professionals within corporations, small businesses, law firms, insurers, banks, non-bank lenders, credit unions, leasing companies, and securities firms. Finally, the Legal & Regulatory segment supplies evidence-based information, actionable insights, and integrated workflow solutions. These tools empower customers to make sound decisions, streamline compliance processes, boost productivity and performance, mitigate risks, and confidently resolve complex challenges. Its clientele comprises legal and compliance professionals, operational risk managers, and environmental, health, and safety managers in law firms, corporations, universities, and government agencies.

Related entities

Subsidiaries (56)
WOLTERS KLUWER FS Austria GmbH
WOLTERS KLUWER HOLDINGS (UK) FSS PENSION TRUSTEE LIMITED
WOLTERS KLUWER ITALIA S.R.L.
Wolters Kluwer Korea, LLC
Wolters Kluwer Legal Software France S.A.S.
Wolters Kluwer Malaysia SDN. BHD.
Wolters Kluwer Nederland B.V.
WOLTERS KLUWER NORGE AS
Wolters Kluwer Philippines, Inc.
Wolters Kluwer Scandinavia AB
WOLTERS KLUWER SINGAPORE PTE. LTD.
Wolters Kluwer TAA TeamMate GmbH
Wolters Kluwer Tax & Accounting Deutschland GmbH
WOLTERS KLUWER TAX AND ACCOUNTING ESPAÑA SL
WOLTERS KLUWER TAX AND ACCOUNTING LIMITED
Wolters Kluwer ČR, a.s.

Key people

Chris Vogelzang
Member of the Supervisory Board · since 2019
IPO date
Jan 02, 1985
Employees
20,921
Domiciled in
NL
Incorporated in
NL
Headquarters & legal address
Zuidpoolsingel 2
Alphen aan den Rijn, ZH 2408 ZE
NL

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT